MLC Medical LLC has completed a distribution agreement with Spain’s Laboratorios Rubió, S.A., a specialty company focused on treatments for chronic renal disease and metabolic conditions.

This partnership introduces Resincalcio® (Calcium Polystyrene Sulfonate) oral suspension powder to Georgia. Resincalcio® acts as a targeted cation exchange resin for the prevention and emergency management of hyperkalemia in acute and chronic renal impairment.

Integrating Resincalcio® expands MLC Medical's nephrology footprint, addressing life-threatening potassium imbalances for dialysis and kidney disease patients.

MLC Medical looks forward to a rewarding partnership with Laboratorios Rubió, delivering specialized nephrology therapies that support clinical teams nationwide.